MNKD - MannKind Corporation Sales Growth YoY (TTM)

Graphic logo of Afrezza (MNKD)

The success of MannKind Corporation (MNKD) relies on patent protection and physician recognition of inhaled insulin delivery methods. Relative revenue growth over the last four quarters compared to the previous year confirms this trend, with the metric reaching 32.30. The development of innovative drug delivery systems mitigates risks, while steady demand for current therapies provides the company with strong financial health and a sustainable cash flow.

Afrezza (MNKD) - Sales Growth YoY (Last Twelve Months) from 02/11/2024 to 11/18/2026

MannKind Corp (MNKD) - metric breakdowns and financial figures

- current quotes and average value forecast:
Analysis of all company metrics:MannKind Corp. - MNKD
Original product of MannKind

Trailing 12-month revenue dynamics allow for the filtering of short-term market volatility, measuring the business's actual ability to scale revenues amid inflation. By analyzing the YoY sales growth over the last four quarters, an investor can see the expansion rates of MannKind Corporation (MNKD), driven by high user loyalty to the inhalation system and a steady influx of patients through FDA-approved distribution channels.

Who MannKind Corporation competes with

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|AMPH: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last 12 Months) TBPH|AQST (Aquestive Corp) - Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) scPharmaceuticals Inc. (SCPH)|Revenue Growth YoY (Last 12 Months) TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) SXT Pharmaceuticals SXTC|Revenue Dynamics YoY (Last Twelve Months) EPRX|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)